Evidence map›Paper›PMID 38107306›Full record

ArticleHeliyon2023

Metastable FeMg particles for controlling degradation rate, mechanical properties, and biocompatibility of Poly(l-lactic) acid (PLLA) for orthopedic applications.

Rafael Guillermo Estrada, Marta Multigner, Natalia Fagali, Rosa María Lozano, Marta Muñoz, Sandra Carolina Cifuentes, Belén Torres, Marcela Lieblich

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Fabrication of Magnetic Poly(L-lactide) (PLLA)/FeMaterials (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Rafael Guillermo EstradaCentro Nacional de Investigaciones Metalúrgicas (CENIM-CSIC), 28040, Madrid, Spain.
Marta MultignerUniversidad Rey Juan Carlos (URJC), 28933, Madrid, Spain.
Natalia FagaliCentro Nacional de Investigaciones Metalúrgicas (CENIM-CSIC), 28040, Madrid, Spain.
Rosa María LozanoCell-Biomaterial Recognition Lab, Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas Margarita Salas (CIB-MS.CSIC), Madrid, Spain.
Marta MuñozUniversidad Rey Juan Carlos (URJC), 28933, Madrid, Spain.
Sandra Carolina CifuentesUniversidad Rey Juan Carlos (URJC), 28933, Madrid, Spain.
Belén TorresUniversidad Rey Juan Carlos (URJC), 28933, Madrid, Spain.
Marcela LieblichCentro Nacional de Investigaciones Metalúrgicas (CENIM-CSIC), 28040, Madrid, Spain.
Universidad Rey Juan Carlos · ESCenim - Centro Nacional de Investigaciones Metalurgicas · ESCentro de Investigaciones Biológicas Margarita Salas · ESConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(l-lactic) acid (PLLA) is commonly used in bioabsorbable medical implants, but it suffers from slow degradation rate and rapid decline in mechanical properties for orthopedic applications. To address this drawback, recent research has explored the use of Mg as a filler for PLLA, resulting in composites with improved degradation rate and cytocompatibility compared to neat PLLA. In this study, FeMg powder particles were proposed as fillers for PLLA to investigate the potential of PLLA/FeMg composites for bioabsorbable implants. Cylinder specimens of PLLA, PLLA/Fe, PLLA/Mg and PLLA/FeMg were prepared using solvent casting followed by thermo-molding. The microstructure, thermal behavior,

Indexed as

Degradable composite biomaterialFeMgMechanical properties¸ cytocompatibilityPLLATemporary orthopedic devices

Identifiers

PMID38107306
PMCPMC10724572
OpenAlexW4388817512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.